These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 28012685

  • 1. pncA mutations are associated with slower sputum conversion during standard treatment of multidrug-resistant tuberculosis.
    Zheng X, Ning Z, Drobniewski F, Yang J, Li Q, Zhang Z, Hu Y.
    Int J Antimicrob Agents; 2017 Feb; 49(2):183-188. PubMed ID: 28012685
    [Abstract] [Full Text] [Related]

  • 2. Impact of genotypic and phenotypic resistance to second-line anti-tuberculosis drugs on treatment outcomes in multidrug-resistant tuberculosis in China.
    Hu Y, Zheng X, Ning Z, Li Q, Zhang Z, Hoffner S.
    Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S34-S35. PubMed ID: 28043597
    [Abstract] [Full Text] [Related]

  • 3. Pyrazinamide Susceptibility and pncA Mutation Profiles of Mycobacterium tuberculosis among Multidrug-Resistant Tuberculosis Patients in Bangladesh.
    Rahman A, Ferdous SS, Ahmed S, Rahman SMM, Uddin MKM, Pholwat S, Gratz J, Houpt E, Banu S.
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630193
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Genotypic characterization of pyrazinamide resistance in Mycobacterium tuberculosis isolated from Lusaka, Zambia.
    Bwalya P, Yamaguchi T, Mulundu G, Nakajima C, Mbulo G, Solo ES, Fukushima Y, Kasakwa K, Suzuki Y.
    Tuberculosis (Edinb); 2018 Mar; 109():117-122. PubMed ID: 29559115
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pyrazinamide resistance among multidrug-resistant tuberculosis clinical isolates in a national referral center of China and its correlations with pncA, rpsA, and panD gene mutations.
    Gu Y, Yu X, Jiang G, Wang X, Ma Y, Li Y, Huang H.
    Diagn Microbiol Infect Dis; 2016 Mar; 84(3):207-11. PubMed ID: 26775806
    [Abstract] [Full Text] [Related]

  • 13. Phenotypic and genotypic characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates in Zhejiang, China.
    Xia Q, Zhao LL, Li F, Fan YM, Chen YY, Wu BB, Liu ZW, Pan AZ, Zhu M.
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1690-5. PubMed ID: 25583712
    [Abstract] [Full Text] [Related]

  • 14. Multicenter Study of the Emergence and Genetic Characteristics of Pyrazinamide-Resistant Tuberculosis in China.
    Li D, Hu Y, Werngren J, Mansjö M, Zheng X, Drobniewski F, Hoffner S, Xu B.
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5159-66. PubMed ID: 27297481
    [Abstract] [Full Text] [Related]

  • 15. Rapid diagnosis of pyrazinamide-resistant multidrug-resistant tuberculosis using a molecular-based diagnostic algorithm.
    Simons SO, van der Laan T, Mulder A, van Ingen J, Rigouts L, Dekhuijzen PN, Boeree MJ, van Soolingen D.
    Clin Microbiol Infect; 2014 Oct; 20(10):1015-20. PubMed ID: 24890253
    [Abstract] [Full Text] [Related]

  • 16. Surveillance of pyrazinamide susceptibility among multidrug-resistant Mycobacterium tuberculosis isolates from Siriraj Hospital, Thailand.
    Jonmalung J, Prammananan T, Leechawengwongs M, Chaiprasert A.
    BMC Microbiol; 2010 Aug 20; 10():223. PubMed ID: 20727143
    [Abstract] [Full Text] [Related]

  • 17. Pyrazinamide resistance in Mycobacterium tuberculosis arises after rifampicin and fluoroquinolone resistance.
    Alame-Emane AK, Xu P, Pierre-Audigier C, Cadet-Daniel V, Shen X, Sraouia M, Siawaya JF, Takiff H, Gao Q, Gicquel B.
    Int J Tuberc Lung Dis; 2015 Jun 20; 19(6):679-84. PubMed ID: 25946359
    [Abstract] [Full Text] [Related]

  • 18. Non-pncA Gene-Mutated but Pyrazinamide-Resistant Mycobacterium tuberculosis: Why Is That?
    Werngren J, Alm E, Mansjö M.
    J Clin Microbiol; 2017 Jun 20; 55(6):1920-1927. PubMed ID: 28404681
    [Abstract] [Full Text] [Related]

  • 19. Pyrazinamide Resistance Assays and Two-Month Sputum Culture Status in Patients with Multidrug-Resistant Tuberculosis.
    Velásquez GE, Calderon RI, Mitnick CD, Becerra MC, Huang CC, Zhang Z, Contreras CC, Yataco RM, Galea JT, Lecca LW, Murray MB.
    Antimicrob Agents Chemother; 2016 Nov 20; 60(11):6766-6773. PubMed ID: 27600032
    [Abstract] [Full Text] [Related]

  • 20. Prevalence and transmission of pyrazinamide resistant Mycobacterium tuberculosis in China.
    Xu P, Wu J, Yang C, Luo T, Shen X, Zhang Y, Nsofor CA, Zhu G, Gicquel B, Gao Q.
    Tuberculosis (Edinb); 2016 May 20; 98():56-61. PubMed ID: 27156619
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.